🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

INTERVIEW-UPDATE 1-Biotech Deinove eyes U.S., Brazil ethanol

Published 04/05/2011, 04:54 AM
Updated 04/05/2011, 05:04 AM

* Deinove in talks with U.S., Brazil firms on biofuels

* Has sugar cane ethanol projects with Tereos Internacional

* Envisages buy-out as soon as 2013

* Shares gain 4.2 percent

(Adds shares, additional details, background)

By Sybille de La Hamaide and Alexandre Boksenbaum-Granier

PARIS, April 5 (Reuters) - French green biotech firm Deinove , which hopes to use a 4 billion year old bacterium to develop the fuel of the future, is eyeing new projects in the United States and Brazil, its chief executive told Reuters.

The company is talks with a large U.S. ethanol maker and with Tereos Internacional, a Brazil-based unit of France's Tereos group, to develop a bioethanol based not only on food but also on a bacterium named deinococcus, discovered in a U.S. corned beef tin in 1956, Deinove CEO Jacques Biton said.

Deinove, which has a market capitalisation of 43 million euros ($61 million), was also negotiating a project in Brazil based on paper pulp, Biton said, but he declined to give further details.

Biton said the company was looking for investors who could provide it with an emergency cash cushion of 1 or 2 million euros and boost development. But he stressed the company, which listed in Paris last year, had enough to last until 2014, when it expects to be profitable.

"What we are looking for are industrial partnerships, and technological, and research, but I would like to have another industrial firm among our shareholders," Biton said in an interview.

He said the firm, created in 2006, which also seeks to apply its technology to antibiotics and green chemistry, could either buy back some of its own shares, take on a new major stakeholder, or even become a takeover target as early as 2013.

"I really think that if we do very well, as soon as 2013 there will be a firm that will want to buy us," he said.

Deinove is controlled by French venture capital fund Truffle Capital, whose stake could fall to 64 percent from 75 percent after some options are exercised. Tereos Internacional, which invested 1 million euros when the company was launched on the Alternext stock exchange in April, has a share of 2.5 percent.

The company's shares were up 4.2 percent at 9.22 euros after Biton's comments to Reuters were made public, bringing the stock's gains to 16 percent since its launch in April 2010. After a poor performance through most of last year it has more than doubled since Jan. 1.

Biton stressed that although Deinove was in talks for a deal, it did not want to rush to sell more biofuel licences and could afford to wait until it further develops its technology.

Deinove is already working with Tereos Internacional on a pilot project due to be launched in 2013 at its wheat-based ethanol plant in France. It is now looking at how to apply the process to Tereos's sugar-cane-based ethanol units in Brazil, Biton said.

The company discovered 7,000 types of deinococchus, dubbed "Conan the Bacterium" for its strength in resisting radioactivity, heat, cold and dehydration, and says it aims to develop "third-generation biofuels" that would go beyond ethanol, which can be corrosive to engines.

"If we want to remain in the race, we need to aim for advanced fuels," Biton said. (Editing by Christian Plumb and Will Waterman) ($1=.7050 Euro)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.